-
Results of a new survey indicate that in women experiencing heavy periods, pain is the most commonly reported problem.1 What are some clinical strategies to help ease these symptoms?
-
Understanding sexual behavior is an important piece of the family planning puzzle, and a new national report provides insights on current sexual practices.1
-
A year after the Food and Drug Administration (FDA) approved behind-the-counter status for the emergency contraceptive (EC) pill Plan B (Barr Pharmaceuticals; Pomona, NY) is the drug more available to women? While the company says sales have increased from about $40 million annually to an expected $80 million for 2007, availability is mixed, according to reports around the country.
-
The next patient in your exam room is an 18-year-old female. What do you think she knows about intrauterine contraception?
-
To obtain up-to-the-minute education on intrauterine contraception, attend A Clinical Update on Intrauterine Contraception continuing medical education program organized by the Association of Reproductive Health Professionals (ARHP).
-
Take that vision and expand it a thousandfold, as evidenced by the New York City Department of Health and Mental Hygiene's new NYC Condom.
-
Results from past research studies have investigated a possible relationship between hormonal contraceptive use and HIV acquisition, but understanding remained poor due to inconsistent results and shortfalls in study design.
-
When it comes to initiating oral contraceptives (OCs), new research indicates that immediate initiation before start of the next menses improves short-term continuation of pill use.
-
Obesity is gaining ground in the United States. Are you prepared to offer women effective options? James Trussell, PhD, professor of economics and public affairs and director of the Office of Population Research at Princeton (NJ) University, reviewed current research at the 2007 Contraceptive Technology conferences to help clinicians select appropriate options.
-
Results of a large national study of young men and women ages 18-27 suggest that Mycoplasma genitalium, a relatively new sexually transmitted infection, surpassed gonorrhea in prevalence.
